FDA/CDC

FDA advisory committee votes to recommend first once-daily aminoglycoside antibiotic

Publish date: May 2, 2018

 

Pages

Recommended Reading

MDedge Daily News: Can a nasal spray reverse suicidality?
MDedge Infectious Disease
No increased intussusception risk from rotavirus vaccine in Africa
MDedge Infectious Disease
Measles exacts high toll among Europe’s youngest citizens
MDedge Infectious Disease
Comorbidity occurs earlier and more commonly with HIV infection
MDedge Infectious Disease
MenB vaccine receives breakthrough therapy designation for children aged 1-9 years
MDedge Infectious Disease
Antiretroviral choice for pregnant women with HIV does not appear to impact birth outcomes
MDedge Infectious Disease
Piperacillin-tazobactam tripled risk of death for patients with cephalosporin-resistant septicemia
MDedge Infectious Disease
International travel updates
MDedge Infectious Disease
HIV infection linked to higher risk of non-melanoma skin cancer
MDedge Infectious Disease
Treatment of HCV in special populations
MDedge Infectious Disease